$3.30
-0.28-7.84%
Pre-Market: 4:37 PM EDT
15 minutes delayed
DiaMedica Therapeutics
DMACNASDAQ
DiaMedica Therapeutics (NASDAQ:DMAC) Stock, Earnings Estimates, EPS, And Revenue
DiaMedica Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 12
EPS Estimate
$-0.160
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Analyze the earnings history of DiaMedica Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMAC | DiaMedica Therapeutics | -$0.16 | -$0.16 | — | — | $0.00 | — | — | — | 08/12/2024 | Get Alert |
| DMAC | DiaMedica Therapeutics | -$0.20 | -$0.16 | -$0.14 | 12.50% | $0.00 | — | $0.00 | — | 05/08/2024 | Get Alert |
| DMAC | DiaMedica Therapeutics | -$0.14 | -$0.14 | -$0.14 | 0.00% | $0.00 | — | $0.00 | — | 03/19/2024 | Get Alert |
| DMAC | DiaMedica Therapeutics | -$0.12 | -$0.13 | -$0.12 | 7.69% | $0.00 | — | $0.00 | — | 11/13/2023 | Get Alert |
| DMAC | DiaMedica Therapeutics | -$0.13 | -$0.18 | -$0.16 | 11.11% | $0.00 | — | $0.00 | — | 08/14/2023 | Get Alert |
| DMAC | DiaMedica Therapeutics | -$0.13 | -$0.16 | -$0.20 | -25.00% | $0.00 | — | $0.00 | — | 05/15/2023 | Get Alert |
| DMAC | DiaMedica Therapeutics | -$0.10 | -$0.14 | -$0.14 | 0.00% | $0.00 | — | $0.00 | — | 03/28/2023 | Get Alert |
| DMAC | DiaMedica Therapeutics | -$0.18 | -$0.15 | -$0.12 | 20.00% | $0.00 | — | $0.00 | — | 11/09/2022 | Get Alert |
| DMAC | DiaMedica Therapeutics | -$0.17 | -$0.18 | -$0.13 | 27.78% | $0.00 | — | $0.00 | — | 08/10/2022 | Get Alert |
| DMAC | DiaMedica Therapeutics | -$0.19 | -$0.21 | -$0.13 | 38.10% | $0.00 | — | $0.00 | — | 05/04/2022 | Get Alert |
| DMAC | DiaMedica Therapeutics | -$0.23 | -$0.18 | -$0.10 | 44.44% | $0.00 | — | $0.00 | — | 03/14/2022 | Get Alert |
| DMAC | DiaMedica Therapeutics | -$0.19 | -$0.23 | -$0.18 | 21.74% | $0.00 | — | $0.00 | — | 11/10/2021 | Get Alert |
| DMAC | DiaMedica Therapeutics | -$0.17 | -$0.21 | -$0.17 | 19.05% | $0.00 | — | $0.00 | — | 08/11/2021 | Get Alert |
| DMAC | DiaMedica Therapeutics | -$0.19 | -$0.21 | -$0.19 | 9.52% | $0.00 | — | $0.00 | — | 05/05/2021 | Get Alert |
| DMAC | DiaMedica Therapeutics | -$0.21 | -$0.17 | -$0.23 | -35.29% | $0.00 | — | $0.00 | — | 03/10/2021 | Get Alert |
| DMAC | DiaMedica Therapeutics | -$0.20 | — | -$0.19 | — | $0.00 | — | $0.00 | — | 11/04/2020 | Get Alert |
| DMAC | DiaMedica Therapeutics | -$0.21 | — | -$0.17 | — | $0.00 | — | $0.00 | — | 08/11/2020 | Get Alert |
| DMAC | DiaMedica Therapeutics | -$0.27 | — | -$0.19 | — | $0.00 | — | $0.00 | — | 05/13/2020 | Get Alert |
| DMAC | DiaMedica Therapeutics | — | — | -$0.21 | — | — | — | $0.00 | — | 03/23/2020 | Get Alert |
| DMAC | DiaMedica Therapeutics | -$0.18 | — | -$0.20 | — | — | — | $0.00 | — | 11/13/2019 | Get Alert |
| DMAC | DiaMedica Therapeutics | -$0.22 | — | -$0.21 | — | — | — | $0.00 | — | 08/13/2019 | Get Alert |
DiaMedica Therapeutics (DMAC) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-08 | $-0.14 | $-0.16 | 12.5 % |
| Dec 2023 | 2024-03-19 | $-0.14 | $-0.14 | 0.00 % |
| Sep 2023 | 2023-11-13 | $-0.12 | $-0.13 | 7.69 % |
| Jun 2023 | 2023-08-14 | $-0.16 | $-0.18 | 11.1 % |
DiaMedica Therapeutics (DMAC) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is DiaMedica Therapeutics (NASDAQ:DMAC) reporting earnings?
DiaMedica Therapeutics (DMAC) is scheduled to report earnings on August 12, 2024. The last reported earnings were for reported on May 8, 2024 for Q1.
What were the latest earnings per share (EPS) for DiaMedica Therapeutics (NASDAQ:DMAC)?
The Actual EPS was $-0.14, which beat the estimate of $-0.16.
What were DiaMedica Therapeutics’s (NASDAQ:DMAC) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.